Skip to content
Cancer diagnosis
Physical examination
Male/Female physical examination plan
Endoscopic examination
X-ray
Ultrasound examination
Laboratory examination
Cytological examination
Pathological diagnosis
Positron emission tomography and computed tomography (PET/CT)
Magnetic resonance imaging (MRI)
Computed tomography (CT) scan
Genetic testing
Cancer treatment
Information for newly diagnosed patients
Surgery
Radiotherapy
Chemotherapy
Side Effect
Chemotherapy Instructions
cancer cell characteristics, and individual constitution.
Gene-directed targeted therapy
Targeted therapy
Hormone therapy
Immunotherapy
Hyperbaric oxygen therapy
Sudden hearing loss
Ischemic stroke / Cerebral stroke
Diabetic foot ulcers
Applications in oncology
Types of cancer
What is cancer
breast cancer
Lung cancer
Lung cancer articles and reports
colorectal cancer
liver cancer
stomach cancer
prostate cancer
thyroid cancer
brain cancer
nasopharyngeal cancer
cervical cancer
pancreatic cancer
Uterine body cancer
Cancer information
New cancer drugs
Lung cancer drugs
Breast cancer drugs
Bile duct cancer drugs
Liver cancer drugs
Bowel cancer drugs
Urothelial carcinoma drugs
Prostate cancer drugs
News report
Cancer information video
Medical lectures
Doctor Q&A
Clinical research
Contact us
Contact methods
Doctor Updates
Join us
繁
En
Cancer diagnosis
Physical examination
Male/Female physical examination plan
Endoscopic examination
X-ray
Ultrasound examination
Laboratory examination
Cytological examination
Pathological diagnosis
Positron emission tomography and computed tomography (PET/CT)
Magnetic resonance imaging (MRI)
Computed tomography (CT) scan
Genetic testing
Cancer treatment
Information for newly diagnosed patients
Surgery
Radiotherapy
Chemotherapy
Side Effect
Chemotherapy Instructions
cancer cell characteristics, and individual constitution.
Gene-directed targeted therapy
Targeted therapy
Hormone therapy
Immunotherapy
Hyperbaric oxygen therapy
Sudden hearing loss
Ischemic stroke / Cerebral stroke
Diabetic foot ulcers
Applications in oncology
Types of cancer
What is cancer
breast cancer
Lung cancer
Lung cancer articles and reports
colorectal cancer
liver cancer
stomach cancer
prostate cancer
thyroid cancer
brain cancer
nasopharyngeal cancer
cervical cancer
pancreatic cancer
Uterine body cancer
Cancer information
New cancer drugs
Lung cancer drugs
Breast cancer drugs
Bile duct cancer drugs
Liver cancer drugs
Bowel cancer drugs
Urothelial carcinoma drugs
Prostate cancer drugs
News report
Cancer information video
Medical lectures
Doctor Q&A
Clinical research
Contact us
Contact methods
Doctor Updates
Join us
繁
En
search
Cancer information
Strategies for the prevention and treatment of gastrointestinal cancer Gastrointestinal cancer teaching cooking: Salt and pepper squid is almost chaotic, Dr. Li Yu Chung, Jacky
Previous page
Previous
Medical Words and Nursing Epi 7 The latest breast cancer hormone therapy and targeted Drugs Zhonghui will explain the different latest treatments for breast cancer Dr. Li Yu Chung, Jacky
Next article
My wife is 54 years old and in good spirits. In June 2019, she underwent surgery to remove a stage II rectal tumor, which did not require follow-up treatment. Her CEA level was 3.2 after the surgery. In June 2020, her CEA level rose to 10, indicating that the colorectal cancer had metastasized to her liver. She started her first treatment course on June 26 (injection of Oxaliplatin plus two weeks of oral Xeloda). After that, she was transferred to a public hospital to receive targeted therapy and chemotherapy. She just completed her first targeted therapy with Cetuximab and her second chemotherapy with Oxaliplatin (Eloxatin), Fluorouracil (5FU), and Folinic Acid on July 15. She was supposed to be hospitalized again in two weeks for continued treatment. Blood tests on July 27th showed low platelet count and high liver enzymes, requiring another blood test on August 3rd to determine if chemotherapy could continue. Unfortunately, the doctor on August 4th said the platelet count was 0.8 and liver enzymes were three times the normal level, so the second targeted therapy and third chemotherapy session could not begin. The next treatment cycle would depend on the blood test results on August 10th, meaning the third chemotherapy session was delayed by three weeks. My question is, my wife's current CEA level of 3.3 is lower than before chemotherapy, but if the blood test results remain unsatisfactory and treatment is delayed, will this affect her condition and drug resistance? Also, how can we increase platelet count and decrease liver enzyme levels during this period? Thank you!
Next
WhatsApp
Facebook
WeChat
Weibo
